Blume-Jensen Peter
- SEC CIK
- 0001950499
In the past year, 1 open-market purchase filing worth $82.1K and 2 sale filings worth $34.4K.
Current role at each company
- ACRV Acrivon Therapeutics, Inc.President and CEOas of Aug 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $82.1K
- 1 filing
- Sold
- $34.4K
- 2 filings
- Net
- +$47.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Blume-Jensen Peter as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 (view filing)4:14 PM ET | Aug 25 | 2 days | Blume-Jensen Peter and 1 otherPresident and CEO | SSale | −14.0K | $2.21 | −$31.0K | −0.6%2.23M after | |
| Aug 20, 2026 (view filing)4:07 PM ET | Aug 18 | 2 days | Blume-Jensen Peter and 1 otherPresident and CEO | SSale | −1.23K | $2.01 | −$2.47K | −0.1%2.24M after | |
| Aug 20, 2026 (view filing)4:07 PM ET | Aug 18 | 2 days | Blume-Jensen Peter and 1 otherPresident and CEO | SSale | −484 | $2.01 | −$972.84 | −0.1%385.9K after | |
| Jan 16, 2026 (view filing)4:02 PM ET | Jan 14 | 2 days | Blume-Jensen Peter and 1 otherPresident and CEO | PPurchase | +49.0K | $1.68 | +$82.1K | +2.4%2.10M after |